Patents by Inventor Heimo Ehmke

Heimo Ehmke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors
    Patent number: 8329716
    Abstract: The invention relates to hetaryloxy-substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: December 11, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Hartmut Schirok, Martin Radtke, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Mark Jean Gnoth, Klaus Münter, Dieter Lang, Santiago Figueroa Perez, Michael Thutewohl, Samir Bennabi, Heimo Ehmke
  • Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
    Patent number: 7737153
    Abstract: The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: June 15, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Achim Feurer, Samir Bennabi, Heike Heckroth, Hartmut Schirok, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Jean Mark Gnoth, Klaus Münter, Dieter Lang, Santiago Figueroa Perez, Heimo Ehmke
  • Substituted phenylamino-pyrimidines
    Patent number: 7723347
    Abstract: The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: May 25, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Hartmut Schirok, Johannes-Peter Stasch, Raimund Kast, Klaus Münter, Marc Jean Gnoth, Santiago Figureoa Perez, Michael Thutewohl, Samir Bennabi, Dieter Lang, Joachim Mittendorf, Martin Radtke, Heimo Ehmke
  • Substituted Phenylamino-Pyrimidines
    Publication number: 20080269268
    Abstract: The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Application
    Filed: April 14, 2005
    Publication date: October 30, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Hartmut Schirok, Johannes-Peter Stasch, Raimund Kast, Klaus Munter, Mark Jean Gnoth, Santiago Figureoa Perez, Michael Thutewohl, Samir Bennabi, Dieter Lang, Joachim Mittendorf, Martin Radtke, Heimo Ehmke
  • Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular Diseases
    Publication number: 20080249105
    Abstract: The invention relates to heteroaryl-substituted benzenes, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Application
    Filed: November 26, 2004
    Publication date: October 9, 2008
    Applicant: Bayer Healthcare AG
    Inventors: Samir Bennabi, Heike Heckroth, Hartmut Schirok, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Mark Jean Gnoth, Klaus Minter, Dieter Lang, Santiago Figueroa Perez, Marcus Bauser, Achim Feurer, Heimo Ehmke
  • Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors
    Publication number: 20080139595
    Abstract: The invention relates to hetaryloxy-substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Application
    Filed: March 30, 2005
    Publication date: June 12, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Hartmut Schirok, Martin Radtke, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Mark Jean Gnoth, Klaus Munter, Dieter Lang, Santiago Figueroa Perez, Michael Thutewohl, Samir Bennabi, Heimo Ehmke
  • Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
    Publication number: 20060241127
    Abstract: The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.
    Type: Application
    Filed: October 16, 2003
    Publication date: October 26, 2006
    Applicant: BAYER HEALTHCARE AG
    Inventors: Achim Feurer, Samir Bennabi, Heike Heckroth, Hartmut Schirok, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Jean Gnoth, Klaus Munter, Dieter Lang, Santiago Perez, Heimo Ehmke